MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore the role of genetic testing in diagnosing Psoriasis 15, pustular susceptibility, shedding light on genetic mutations, personalized treatments, and disease progression.
Explore PURA-related neonatal syndrome, its genetic basis, and the role of testing. Learn about symptoms, early intervention, and family planning insights.
Explore how genetic testing uncovers connections between retinal dystrophy and obesity, highlighting Alström Syndrome, personalized treatment, and family insights.
Explore retinal dystrophy with inner retinal dysfunction. Discover how genetic testing revolutionizes diagnosis, personalized treatments, and early interventions.
Explore the impact of genetic testing on Retinitis Pigmentosa 70, from early detection and personalized treatments to family planning and advancing research.
Explore the role of genetic testing in diagnosing Retinitis Pigmentosa-Juvenile Cataract syndrome. Understand genetic insights and management strategies.
Unlock the potential of genetic testing for Severe Combined Immunodeficiency due to CTPS1 deficiency. Early diagnosis, family planning, and personalized treatments await.
Uncover how genetic testing aids in early SCID diagnosis, carrier screening, and personalized treatment, transforming outcomes for those with DNA-PKcs deficiency.